FindTrial
Sign In

Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19)

Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000002996
Enrollment
Unknown
Registered
2020-02-04
Start date
2020-01-29
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

Experimental group 1 (moderate):Compound Yinchai granules 15g, Qingqiao antiviral granules 15g, q4hwith warm water
Experimental group 1 (mild):Compound Yinchai granules 15g, Qingqiao antiviral granules 15g, tid,with warm water

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Conform to the western medicine influenza diagnostic criteria 2. Conform to the diagnostic criteria of TCM wind-heat clip dampness syndrome 3. Over 18 years old

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
blood routine examination;D-Dimer;Mb;creatase;ESR;CRP;Tn;chest CT;PCT;—

Countries

China

Contacts

Public ContactXie Chunguang

Hospital of Chengdu University of Traditional Chinese Medicine

xcg718@aliyun.com+86 18980880132

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026